Lifecare investor presentation – Redeye Diabetes Event

Lifecare will attend the Redeye Diabetes Event 2023 today and presents the
company's technology status and development at 11:05 AM CEST. 

The presentations are live broadcasted at
https://www.redeye.se/events/870294/redeye-theme-diabetes and the presentation
slides is enclosed to this notification. 


ABOUT LIFECARE
Lifecare AS is a clinical stage medical sensor company developing technology for
sensing and monitoring of various body analytes. Lifecare's main focus is to
bring the next generation of Continuous Glucose Monitoring ("CGM") systems to
market. Lifecare enables osmotic pressure as sensing principle, combined with
the ability to manipulate Nano-granular Tunnelling Resistive sensors ("NTR") on
the sensor body for read-out of pressure variations. LifecareŽs sensor
technology is referred to as "Sencell" and is suitable for identifying and
monitoring the occurrence of a wide range of analytes and molecules in the human
body. 

Further information Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no,
+47 40 05 90 40 

This stock exchange announcement was published by Joacim Holter, CEO at Lifecare
AS, on 24 May 2023 at 08:45 CET.